High CHRAC1 mRNA level was correlated with decreased overall and disease-free survival in cases of CESC and other tumor types by using the Gene Expression Profiling Interactive Analysis version 2 (GEPIA2) tool (Figs. 2C–2E, Figs. S1B–S1K). The gene discussed is CHRAC1; the disease is neoplasm.